First Trust Advisors LP Anavex Life Sciences Corp. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$16.82 - $25.75 $2.99 Million - $4.58 Million	-177,823 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.16 - $28.86 $50,454 - $143,318	-4,966 Reduced 2.72%	177,823 $4.07 Million
Q1 2021 May 14, 2021	BUY	$5.17 - $16.13 $192,137 - $599,455	37,164 Added 25.52%	182,789 $2.73 Million
Q4 2020 Feb 02, 2021	SELL	$4.01 - $7.58 $26,393 - $49,891	-6,582 Reduced 4.32%	145,625 $786,000
Q3 2020 Nov 05, 2020	BUY	$3.8 - $5.0 $578,386 - $761,035	152,207 New	152,207 $693,000

163

27.5M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.